1. Home
  2. GRC vs FTRE Comparison

GRC vs FTRE Comparison

Compare GRC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$61.25

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.02

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
FTRE
Founded
1933
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
GRC
FTRE
Price
$61.25
$9.02
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.39
AVG Volume (30 Days)
124.9K
1.4M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
1.22%
N/A
EPS Growth
32.03
N/A
EPS
2.02
N/A
Revenue
$682,389,000.00
$2,723,400,000.00
Revenue This Year
$6.62
N/A
Revenue Next Year
$4.66
$3.01
P/E Ratio
$31.00
N/A
Revenue Growth
3.44
1.00
52 Week Low
$30.87
$3.97
52 Week High
$68.02
$18.67

Technical Indicators

Market Signals
Indicator
GRC
FTRE
Relative Strength Index (RSI) 48.96 35.46
Support Level $56.98 $8.85
Resistance Level $67.61 $11.22
Average True Range (ATR) 2.36 0.57
MACD -0.01 0.16
Stochastic Oscillator 51.50 26.11

Price Performance

Historical Comparison
GRC
FTRE

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: